Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage

Breast Cancer Research and Treatment

Volumn 37, Issue 3, 1996, Pages 229-236

  Stomper, Paul C ^a,c   Penetrante, Remedios B ^b   Edge, Stephen B ^a   Arredondo, Mark A ^a   Blumenson, Leslie E ^a   Stewart, Carleton C ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

DNA analysis; Mammographic parenchymal patterns

Indexed keywords

ADIPOSE TISSUE; ADULT; AGE; AGED; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADIPOSE TISSUE; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST; CELL DIVISION; DNA; FEMALE; HUMANS; HYPERPLASIA; MAMMOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDIES; S PHASE;

EID: 0030033855     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806504     Document Type: Article

References (22)

1. Wellings SR, Wolfe JN: Correlative studies of the histological and radiographic appearance of the breast parenchyma. Radiology 129: 299-306, 1978
2. Fisher ER, Palekar A, Kim WS, Redmond C: The histopathology of mammographic patterns. Am J Clin Pathol 69:421-426, 1978
3. Stomper PC, Stewart CC, Penetrante RB, Nava MER, Tsangaris TN: Flow cytometric DNA analysis of excised breast lesions: Use of fresh tissue needle aspirates obtained under guidance with mammography of the specimen. Radiology 185: 415-422, 1992
4. Page DL, Anderson TJ: Diagnostic histopathology of the breast. New York: Churchill Livingstone, 1987, pp. 137-145
5. Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH: Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61: 1055-1063, 1978
6. Fleiss JL: Statistical methods for rates and proportions, 2nd edition. New York: John Wiley & Sons, 1981, pp. 20-27
7. Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37: 2486-2492, 1976
8. Boyd NF, O'Sullivan B, Fishell E, Simor I, Cooke G: Mammographic patterns and breast cancer risk: Methodologic standards and contradictory results. JNCI 72: 1253-1259, 1984
9. Brisson J, Morrison AS, Kopans DB, Sadowsky NL, Kalisher L, Twaddle JA, Meyer JE, Henschke CI, Cole P: Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 119: 371-381, 1984
10. Brisson J, Morrison AS, Khalid N: Mammographic parenchymal features and breast cancer in the Breast Cancer Detection Demonstration Project. JNCI 80: 1534-1540, 1988
11. Saftlas AF, Wolfe JN, Hoover RN, Brinton LA, Schairer C, Salane M, Szklo M: Mammographic parenchymal patterns as indicators of breast cancer risk. Am J Epidemiol 129: 518-526, 1989
12. Tabar L, Dean PB: Mammographic parenchymal patterns. Risk indicator for breast cancer? JAMA 247: 185-189, 1982
13. deWaard F, Rombach JJ, Collette HJA, Stotboom B: Breast cancer risk associated with reproductive factors and breast parenchymal patterns. J Natl Cancer Inst 72: 1277-1282, 1984
14. Page DL, Winfield AC: The dense mammogram. AJR 147: 487-489, 1986
15. Stomper PC, Cholewinski SP, Penetrante RB, Harlos JP, Tsangaris TN: Atypical hyperplasia: Frequency and mammographic and pathologic relationships in excisional biopsies guided with mammography and clinical examination. Radiology 189: 667-671, 1993
16. Dupont WD, Pari FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD: Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71: 1258-1265, 1993
17. Hedley DW, Rugg CA, Gelber RD: Association of DNA index and S-phase fraction with prognosis of node positive early breast cancer. Cancer Res 47: 4729-4735, 1987
18. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, Lehtinen M, Koivula T: Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. Cancer 62: 2183-2190, 1988
19. Dressier LG, Gray R, Tormey DC et al.: Prediction of recurrence and therapy response in the node negative breast cancer patient by DNA flow cytometry: An Eastern Cooperative Oncology Group (ECOG) intergroup study. Breast Cancer Res Treat 14: 133-187, 1989
20. Winchester DJ, Duda RB, August CZ, Goldschmidt RA, Wruck DM, Rademaker AW, Winchester DP, Merkel DE: The importance of DNA flow cytometry in node-negative breast cancer. Arch Surg 125: 886-889, 1990
21. Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, Siderits R: DNA flow cytometric analysis of primary operable breast cancer. Cancer 68: 1465-1475, 1991
22. Hatschek T, Gröntoft O, Fagerberg G, Stal O, Sullivan S, Carstensen J, Nordenskjold B: Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: Correlation and relative prognostic influence. Breast Cancer Res Treat 15: 149-160, 1990